Life Science News
Latest updates from the biotech and pharma world
Genmab terminates Phase 3 lung cancer asset that BioNTech ditched
#SABCS25: BioNTech, BMS unwrap Phase 2 data for PD-L1xVEGF-A bispecific in breast cancer
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing - Pharmaceutical Technology
#Lonza invest#Pharmaceutical Technology#FDA filing#BioNTech adds#adds CMOs